Methamphetamine induces cytosolic Ca2+ oscillations in the VTA dopamine neurons

NeuroReport

Volumn 11, Issue 5, 2000, Pages 1057-1061

  Uramura, Kazuhide ^a   Yada, Toshihiko ^a,b   Muroya, Shinji ^a   Shioda, Seiji ^c   Shiratani, Toshihiro ^a   Takigawa, Morikuni ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

A10; Ca2+ channel blockers; Ca2+ oscillations; Cytosolic Ca2+ concentrations; Dopamine neuron; Drug abuse; Methamphetamine; Schizophrenia; Ventral tegmental area; VTA

Indexed keywords

CALCIUM; METHAMPHETAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM SIGNALING; DOPAMINERGIC NERVE CELL; DRUG ABUSE; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

EID: 0034615836     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004070-00031     Document Type: Article

References (25)

1. 1. Blackburn JR, Pfaus JG and Phillips AG. Prog Neurobiol 39, 247-279 (1992).
2. 2. Koob GF. Trends Pharmacol Sci 13, 177-184 (1992).
3. 3. Le Moal M and Simon H. Physiol Rev 71, 155-234 (1991).
4. 4. Kalivas PW and Stewart J. Brain Res Rev 16, 223-244 (1991).
5. 5. Nishikawa T, Mataga N, Takashima M and Toru M. Eur J Pharmacol 88, 195-203 (1983).
6. 6. Ellinwood EH, Sudilovsky A and Nelson LM. Am J Psychiatry 130, 1088-1093 (1973).
7. 7. Robinson TE and Becker JB. Brain Res Rev 11, 157-198 (1986).
8. 8. Wolf ME, White FJ, Nassar R et al. J Pharmacol Exp Ther 264, 249-255 (1993).
9. 9. Suzuki H, Shishido T, Watanabe Y et al. Prog Neuropsychopharmacol Biol Psychiatry 21, 359-369 (1997).
10. 10. Stewart J and Vezina P. Brain Res 495, 401-406 (1989).
11. 11. Cador M, Bjijou Y, and Stinus L. Neuroscience 65, 385-395 (1995).
12. 12. Perugini M and Vezina P. J Pharmacol Exp Ther 270, 690-696 (1994).
13. 13. Fisher TE and Bourque CW. J Physiol 486.3, 571-580 (1995).
14. 14. Muroya S, Yada T, Shioda S and Takigawa M. Neurosci Lett 264, 113-116 (1999).
15. 15. Funahashi H, Yada T, Muroya S et al. Neurosci Lett 264, 117-120 (1999).
16. 16. Yada T, Sakurada M, Ihida K et al. J Biol Chem 269, 1290-1293 (1994).
17. 17. Kalivas PW and Weber B. J Pharmacol Exp The 245, 1095-1102 (1988).
18. 18. Paulson PE and Robinson TE. Psychopharmacol 104, 140-141 (1991).
19. 19. Gilon P, Shepherd RM and Henquin JC. J Biol Chem 268, 22265-22268 (1993).
20. 20. Dolmetsch RE, Xu K and Lewis RS. Nature 392, 933-936 (1998).
21. 21. Li W, Llopis J, Whitney M et al. Nature 392, 936-941 (1998).
22. 22. Ogura H, Furuya Y, Teramoto T et al. Peptides 19, 1017-1022 (1998).
23. 23. Hori Y, Takeda H, Tsuji M and Matsumiya T. Pharmacol 56, 165-174 (1998).
24. 24. Sonsalla PK, Nicklas WJ and Heikkila RE. Science 243, 398-400 (1989).
25. 25. LaVoie MJ and Hastings TG. J Neurosci 19, 1484-1491 (1999).